Research Sample bioBank

Small Cell Lung Cancer (SCLC) Clinical Research Samples

Discovery Life Sciences provides the highest quality Small Cell Lung Cancer (SCLC) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Small Cell Lung Cancer (SCLC) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 16 of 16 total samples
 (0)
Checkout
Advanced Data View:
Showing 16 of 16 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Information 3Additional Data 3Additional Detail 3Additional Information 4Additional Data 4Additional Information 5Additional Data 5Additional Detail 5Additional Information 6Additional Data 6Additional Information 7Additional Data 7ICD10 codes
DLS11-0177Small Cell Lung Cancer (SCLC)RussiaSerum1.003.00$50.0061 YMWhite<-70°C04-Apr-12Stage and GradeStage II; T2NisM0; Grade G3$50.001st Degree Relative with CancerNoSmoking HistoryCurrent; 16-20 per dayConcurrent Medical ConditionsChronic Bronchitis; Arterial HypertensionImaging ResultsMass Detected: 3.2 cmPresence of Pleural EffusionDiagnosis After SurgeryMalignant; Right Lung; Combined Small Cell Carcinoma
DLS11-0182Small Cell Lung Cancer (SCLC)RussiaSerum1.002.00$50.0061 YMWhite<-70°C16-Apr-12Stage and GradeStage III; T3N2M0; Grade G3$50.001st Degree Relative with CancerNoSmoking HistoryCurrent; 10-12 per dayConcurrent Medical ConditionsArterial HypertensionImaging ResultsMass Detected: 6.2 cmPresence of Pleural Effusion; Bilateral LesionDiagnosis After SurgeryMalignant; Left Lung; Combined Small Cell Carcinoma
DLS11-0184Small Cell Lung Cancer (SCLC)RussiaSerum1.002.00$50.0059 YMWhite<-70°C05-May-12Stage and GradeStage III; T2N2M0; Grade G3$50.001st Degree Relative with CancerNoSmoking HistoryCurrent; 12-16 per dayConcurrent Medical ConditionsArterial Hypertension; Chronic PyelonephritisImaging ResultsMass Detected: 3.8 cmPresence of Pleural Effusion; Evidence of Distant MetastasisDiagnosis After SurgeryMalignant; Left Lung; Combined Small Cell Carcinoma
DLS11-0185Small Cell Lung Cancer (SCLC)RussiaSerum1.002.00$50.0069 YMWhite<-70°C23-Jan-12Stage and GradeStage II T2N1M0; Grade Not Determined$50.001st Degree Relative with CancerNoSmoking HistoryFormer; 18-20 per dayConcurrent Medical ConditionsArterial Hypertension; Chronic ProstatitisImaging ResultsMass Detected: 3.2 cmDiagnosis After SurgeryMalignant; Left Lung; Combined Small Cell Carcinoma
DLS11-0190Small Cell Lung Cancer (SCLC)RussiaSerum1.002.00$50.0062 YMWhite<-70°C10-Apr-12Stage and GradeStage III; T3N2M0; Grade G3$50.001st Degree Relative with CancerNoSmoking HistoryCurrent; 12-18 per dayConcurrent Medical ConditionsChronic Bronchitis; Arterial HypertensionImaging ResultsMass Detected: 4.3 cmPresence of Pleural Effusion; Evidence of distant metastatisDiagnosis After SurgeryMalignant; Right Lung; Combined Small Cell Carcinoma
DLS17-049949-SSmall Cell Lung Cancer (SCLC)RussiaSerum1.005.00$150.0066 YMWhite<-70C23-Nov-17StagingIIIa; T4N1M0G428-Nov-17Pre-Treatment$150.00Height | Weight179 cm | 74 kgSmoking HistoryFormer 10-20 cigs/day for 30 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT4-Nov-17Site of Primary TumorRight lung (lower lobe)History of Benign Disease Prior to Cancer DiagnosisNoSite of MetastasisN/ACurrent MedicationsBisoprolol, Amlodipine, CaptoprilC34.32
DLS17-049952-SSmall Cell Lung Cancer (SCLC)RussiaSerum1.006.00$150.0056 YMWhite<-70C29-Nov-17StagingIIIa; T3N2M0G36-Dec-17Pre-Treatment$150.00Height | Weight169 cm | 72 kgSmoking HistoryFormer 15-20 cigs/day for 25 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT6-Nov-17Site of Primary TumorRight bronchus (upper lobe)History of Benign Disease Prior to Cancer DiagnosisChronic BronchitisSite of MetastasisN/ACurrent MedicationsOmeprazole, DrotaverineC34.11
DLS17-049955-SSmall Cell Lung Cancer (SCLC)RussiaSerum1.004.00$150.0062 YMWhite<-70C15-Nov-17StagingIIIa; T4N1M0G321-Nov-17Pre-Treatment$150.00Height | Weight178 cm | 84 kgSmoking HistoryFormer 15-20 cigs/day for 35 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT25-Oct-17Site of Primary TumorLeft lung (lower lobe)History of Benign Disease Prior to Cancer DiagnosisNoSite of MetastasisN/ACurrent MedicationsNifedipine, CaptoprilC34.32
DLS17-049977-SSmall Cell Lung Cancer (SCLC)RussiaSerum1.004.00$150.0058 YMAsian<-70C26-Dec-17StagingIIIa; T3N2M0G34-Jan-18Pre-Treatment$150.00Height | Weight180 cm | 92 kgSmoking HistoryFormer 10-15 cigs/day for 20 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT3-Dec-17Site of Primary TumorRight lung (middle lobe)History of Benign Disease Prior to Cancer DiagnosisChronic BronchitisSite of MetastasisN/ACurrent MedicationsNoneC34.21
DLS17-049979-S-HZSmall Cell Lung Cancer (SCLC)RussiaSerum1.004.00$150.0062 YMWhite<-70C12-Dec-17StagingIib; T2N1M0G318-Dec-17Pre-Treatment$150.00Height | Weight184 cm | 81 kgSmoking HistoryFormer 15-20 cigs/day for 35 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT20-Nov-17Site of Primary TumorLeft lung (upper lobe)History of Benign Disease Prior to Cancer DiagnosisChronic BronchitisSite of MetastasisN/ACurrent MedicationsHydrochlorothiazide, Amlodipine, FosinoprilC34.12
DLS17-049949-K2Small Cell Lung Cancer (SCLC)RussiaK2 EDTA Plasma1.003.00$150.0066 YMWhite<-70C23-Nov-17StagingIIIa; T4N1M0G428-Nov-17Pre-Treatment$150.00Height | Weight179 cm | 74 kgSmoking HistoryFormer 10-20 cigs/day for 30 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT4-Nov-17Site of Primary TumorRight lung (lower lobe)History of Benign Disease Prior to Cancer DiagnosisNoSite of MetastasisN/ACurrent MedicationsBisoprolol, Amlodipine, CaptoprilC34.32
DLS17-049952-K2Small Cell Lung Cancer (SCLC)RussiaK2 EDTA Plasma1.003.00$150.0056 YMWhite<-70C29-Nov-17StagingIIIa; T3N2M0G36-Dec-17Pre-Treatment$150.00Height | Weight169 cm | 72 kgSmoking HistoryFormer 15-20 cigs/day for 25 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT6-Nov-17Site of Primary TumorRight bronchus (upper lobe)History of Benign Disease Prior to Cancer DiagnosisChronic BronchitisSite of MetastasisN/ACurrent MedicationsOmeprazole, DrotaverineC34.11
DLS17-049955-K2Small Cell Lung Cancer (SCLC)RussiaK2 EDTA Plasma1.003.00$150.0062 YMWhite<-70C15-Nov-17StagingIIIa; T4N1M0G321-Nov-17Pre-Treatment$150.00Height | Weight178 cm | 84 kgSmoking HistoryFormer 15-20 cigs/day for 35 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT25-Oct-17Site of Primary TumorLeft lung (lower lobe)History of Benign Disease Prior to Cancer DiagnosisNoSite of MetastasisN/ACurrent MedicationsNifedipine, CaptoprilC34.32
DLS17-049977-K2Small Cell Lung Cancer (SCLC)RussiaK2 EDTA Plasma1.003.00$150.0058 YMAsian<-70C26-Dec-17StagingIIIa; T3N2M0G34-Jan-18Pre-Treatment$150.00Height | Weight180 cm | 92 kgSmoking HistoryFormer 10-15 cigs/day for 20 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT3-Dec-17Site of Primary TumorRight lung (middle lobe)History of Benign Disease Prior to Cancer DiagnosisChronic BronchitisSite of MetastasisN/ACurrent MedicationsNoneC34.21
DLS17-049979-K2-HZSmall Cell Lung Cancer (SCLC)RussiaK2 EDTA Plasma1.003.00$150.0062 YMWhite<-70C12-Dec-17StagingIIb; T2N1M0G318-Dec-17Pre-Treatment$150.00Height | Weight184 cm | 81 kgSmoking HistoryFormer 15-20 cigs/day for 35 years Date of Initial Primary Tumor DiagnosisBronchoscopy, Rx, CT20-Nov-17Site of Primary TumorLeft lung (upper lobe)History of Benign Disease Prior to Cancer DiagnosisChronic BronchitisSite of MetastasisN/ACurrent MedicationsHydrochlorothiazide, Amlodipine, FosinoprilC34.12
DLS0063815-SSmall Cell Lung Cancer (SCLC)USASerum1.009.00$200.0064 YMWhite<-70C23-Aug-18StagingAdvanced19-Jul-18$200.00Height | Weight172.7 cm | 85.5 kgSmoking HistoryPrevious-100-pack-yearsDate of Initial Primary Tumor Diagnosis1/31/2018Site of Primary TumorLeft Upper Lobe History of Benign Disease Prior to Cancer DiagnosisHypertension, hyperlipidemia, BPH, anxiety, arthritis, vertigoSite of MetastasisSpineCurrent Prescription MedicationsPotassium phosphate, ranitidine 300 mg, senokot 8.6 mg, Symbicort, tamsulosin 0.4 mg, acetaminophen 500 mg, Ativan 0.5 mg, atorvastatin 20 mg, Compazine 10 mg, cyclobenzaprine 10 mg, dexamethasone 4mg, docusate sodium 100 mg, miralax, ondansetron 8 mg, oxycodone 5 mg

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.